Compare PACB & TCPC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | PACB | TCPC |
|---|---|---|
| Founded | 2000 | 2006 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Laboratory Analytical Instruments | Finance/Investors Services |
| Sector | Industrials | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 419.8M | 407.2M |
| IPO Year | 2010 | 2006 |
| Metric | PACB | TCPC |
|---|---|---|
| Price | $1.25 | $3.45 |
| Analyst Decision | Buy | Sell |
| Analyst Count | 5 | 2 |
| Target Price | $2.10 | ★ $3.50 |
| AVG Volume (30 Days) | ★ 4.8M | 1.6M |
| Earning Date | 05-07-2026 | 05-07-2026 |
| Dividend Yield | N/A | ★ 21.05% |
| EPS Growth | ★ N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $93,468,000.00 | N/A |
| Revenue This Year | $11.22 | N/A |
| Revenue Next Year | $12.41 | N/A |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | ★ 3.04 | N/A |
| 52 Week Low | $0.85 | $3.47 |
| 52 Week High | $2.73 | $8.11 |
| Indicator | PACB | TCPC |
|---|---|---|
| Relative Strength Index (RSI) | 34.36 | 29.35 |
| Support Level | $1.19 | N/A |
| Resistance Level | $1.37 | $5.99 |
| Average True Range (ATR) | 0.09 | 0.13 |
| MACD | 0.01 | 0.03 |
| Stochastic Oscillator | 6.82 | 0.91 |
Pacific Biosciences of California Inc is a biotechnology company focused on designing, developing, and manufacturing sequencing solutions that enable scientists and clinical researchers to improve their understanding of the genome and ultimately, resolve genetically complex problems. It operates in, one reportable segment: the development, manufacturing, and marketing of an integrated platform for genetic analysis. The majority of the company's revenue is derived from Americas, followed by Europe Middle East, and Africa and Asia-Pacific.
BlackRock TCP Capital Corp is an externally-managed specialty finance company focused on middle-market lending. Its investment objective is to achieve high total returns through current income and capital appreciation, with an emphasis on principal protection. It seeks to achieve investment objective through investments in debt securities of middle-market companies. The group generates returns through a combination of the receipt of contractual interest payments on debt investments and origination and similar fees, and, to a lesser extent, equity appreciation through options, warrants, conversion rights or direct equity investments.